Login Start free

Focus

Drug Discovery Investors: Angels and VC Firms

The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.

Strongest in New York, San Francisco and Boston

Common stages: Seed and Series A

4,683: Drug Discovery investors
239: Angel investors
4,444: People at VC/PE firms
1,313: Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

4,683 Drug Discovery investors

Showing 641-660

Filters

Viewing

Drug Discovery4,683

Investor Type

Choosing one replaces Drug Discovery.

Investment Stage

Choosing one replaces Drug Discovery.

Seed84,745
Series A53,997
Late-Stage37,937
Series B35,865
Growth34,738
Pre-Seed32,477

Investment Profile

Choosing one replaces Drug Discovery.

SaaS63,483
FinTech54,183
Healthcare53,462
Consumer46,735
AI46,189
Hardware36,507
Commerce32,773
Climate23,313
Real Estate17,905
Education13,608
Food10,848
Travel7,450
Energy946
Agriculture555

Country

Choosing one replaces Drug Discovery.

City

Choosing one replaces Drug Discovery.

Focus1

Investor	Location	Type	Markets	Contact	Actions
Guillermo Salanueva Investor at Clave Capital	Pamplona, Spain	Venture capital	AIClimate		View profile
Ibrahim Lasis Nucleus Ventures at Nucleus Fund	Lagos, Nigeria	AcceleratorVenture capital	AIClimate		View profile
Jinhee Jeon Affiliated at Yozma Group	South Korea	Venture capital	AIConsumer		View profile
Cordelia H. Investor & Strategic Advisor at 5AM Ventures	San Francisco, United States	Venture capital	Healthcare		View profile
Jonah Gleitman Investor at Entrepreneurs First	Austin, United States	AcceleratorVenture capital	AIHardware		View profile
Mark Siegel Managing Director at Menlo Ventures	Jackson, United States	Angel	AIFinTech		View profile
Usher LiD Affiliated at Humanwell	Wuhan, China	Corporate VC	Healthcare		View profile
Christopher Marino Principal at Blue Owl Capital	New York City, United States	Private equityVenture debt	FinTechHealthcare		View profile
Smac . Partner at Compound	United States	Venture capital	AIFinTech		View profile
Tessa Swanton Postdoctoral Researcher at The Francis Crick Institute	London, United Kingdom	Government-backed	AIHealthcare		View profile
Nojus Dikšaitis Founder at Entrepreneurs First	Vilnius, Lithuania	AcceleratorVenture capital	AIHardware		View profile
Sebastian Lopez Venture Capital Professional at TVM Capital Life Science	United Arab Emirates	Venture capital	ConsumerHardware		View profile
Julie Cherrington Board Member at Syncona Partners	San Francisco, United States	Private equityVenture capital	Healthcare		View profile
Stephen Parks Investor at Topspin Partners	Tampa, United States	Private equityVenture capital	ConsumerHealthcare		View profile
Wentao Yan Investor at Hillhouse Investment	Beijing, China	Private equityVenture capital	AIClimate		View profile
Anita Middleton Biopharmaceutical Investment Manager at Merck Group	San Francisco, United States	Corporate VC	Healthcare		View profile
Gabriel Tse Investor at Milky Way Ventures	Hong Kong	Accelerator	CommerceFood		View profile
Mathijs van Rijk Investor at Innovationquarter	Amsterdam, Netherlands	Government-backed	AIClimate		View profile
Asia Agnelli General Partner at Tmv	New York, United States	Venture capital	AIClimate		View profile
Varishna Sardjoe Mishre Investor at Innovationquarter	Amsterdam, Netherlands	Government-backed	AIClimate		View profile

Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal